Biologically effective dose and prediction of obliteration of unruptured arteriovenous malformations treated by upfront Gamma Knife radiosurgery: a series of 149 consecutive cases

Arteriovenous malformations (AVMs) present no pathologic tissue, and radiation dose is confined in a clear targeted volume. The authors retrospectively evaluated the role of the biologically effective dose (BED) after Gamma Knife radiosurgery (GKRS) for brain AVMs. A total of 149 consecutive cases o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurosurgery 2021-06, Vol.134 (6), p.1901-1911
Hauptverfasser: Tuleasca, Constantin, Peciu-Florianu, Iulia, Leroy, Henri-Arthur, Vermandel, Maximilien, Faouzi, Mohamed, Reyns, Nicolas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1911
container_issue 6
container_start_page 1901
container_title Journal of neurosurgery
container_volume 134
creator Tuleasca, Constantin
Peciu-Florianu, Iulia
Leroy, Henri-Arthur
Vermandel, Maximilien
Faouzi, Mohamed
Reyns, Nicolas
description Arteriovenous malformations (AVMs) present no pathologic tissue, and radiation dose is confined in a clear targeted volume. The authors retrospectively evaluated the role of the biologically effective dose (BED) after Gamma Knife radiosurgery (GKRS) for brain AVMs. A total of 149 consecutive cases of unruptured AVMs treated by upfront GKRS in Lille University Hospital, France, were included. The mean length of follow-up was 52.9 months (median 48, range 12-154 months). The primary outcome was obliteration, and the secondary outcome was complication appearance. The marginal dose was 24 Gy in a vast majority of cases (n = 115, 77.2%; range 18-25 Gy). The mean BED was 220.1 Gy2.47 (median 229.9, range 106.7-246.8 Gy2.47). The mean beam-on time was 32.3 minutes (median 30.8, range 9-138.7 minutes). In the present series, the mean radiation dose rate was 2.259 Gy/min (median 2.176, range 1.313-3.665 Gy/min). The Virginia score was 0 in 29 (19.5%), 1 in 61 (40.9%), 2 in 41 (27.5%), 3 in 18 (12.1%), and 4 in 0 (0%) patients, respectively. The mean Pollock-Flickinger score was 1.11 (median 1.52, range 0.4-2.9). Univariate (for obliteration and complication appearance) and multivariate (for obliteration only) analyses were performed. A total of 104 AVMs (69.8%) were obliterated at the last follow-up. The strongest predictor for obliteration was BED (p = 0.03). A radiosurgical obliteration score is proposed, derived from a fitted multivariable model: (0.018 × BED) + (1.58 × V12) + (-0.013689 × beam-on time) + (0.021 × age) - 4.38. The area under the receiver operating characteristic curve was 0.7438; after internal validation using bootstrap methods, it was 0.7088. No statistically significant relationship between radiation dose rate and obliteration was found (p = 0.29). Twenty-eight (18.8%) patients developed complications after GKRS; 20 (13.4%) of these patients had transient adverse radiological effects (perilesional edema developed). Predictors for complication appearance were higher prescription isodose volume (p = 0.005) and 12-Gy isodose line volume (V12; p = 0.001), higher Pollock-Flickinger (p = 0.02) and Virginia scores (p = 0.003), and lower beam-on time (p = 0.03). The BED was the strongest predictor of obliteration of unruptured AVMs after upfront GKRS. A radiosurgical score comprising the BED is proposed. The V12 appears as a predictor for both efficacy and toxicity. Beam-on time was illustrated as statistically significant for both obliteration and c
doi_str_mv 10.3171/2020.4.JNS201250
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2427296367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2427296367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-d2f8556f082b0a27fabdd0531e4094fe8028f2882cc785301484e0eb4972e21b3</originalsourceid><addsrcrecordid>eNo9kc1u1TAQRi0EopfCnhXykk1ux2MnTthBVUqhggWwjhxnXBklcbDjSve5eEF8-7eybJ_vaEYfY28F7KXQ4gwBYa_2X7__RBBYwzO2E52UFTSdfM52AIiVhLY-Ya9S-gMgGtXgS3YiUYOua71j_z75MIUbb800HTg5R3bzt8THkIibZeRrpNGXt7Dw4HgYJr9RNI_3vMS8brkw3MTy4cMtLSEnPpvJhTjfgYlvkcxWmOHA8-piWDZ-aebZ8G-Ld8SjGX1IOd5QPHzghqcionT0C9VxWwxk891Y1iRKr9kLZ6ZEbx7OU_b788Wv8y_V9Y_Lq_OP15WVSmzViK6t68ZBiwMY1M4M4wi1FKSgU45awNZh26K1uq0lCNUqAhpUp5FQDPKUvb_3rjH8zZS2fvbJ0jSZhcqOPSrU2DWy0QWFe9TGkFIk16_RzyYeegH9sar-WFWv-qeqSuTdgz0PM41Pgcdu5H87T5MO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2427296367</pqid></control><display><type>article</type><title>Biologically effective dose and prediction of obliteration of unruptured arteriovenous malformations treated by upfront Gamma Knife radiosurgery: a series of 149 consecutive cases</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Tuleasca, Constantin ; Peciu-Florianu, Iulia ; Leroy, Henri-Arthur ; Vermandel, Maximilien ; Faouzi, Mohamed ; Reyns, Nicolas</creator><creatorcontrib>Tuleasca, Constantin ; Peciu-Florianu, Iulia ; Leroy, Henri-Arthur ; Vermandel, Maximilien ; Faouzi, Mohamed ; Reyns, Nicolas</creatorcontrib><description>Arteriovenous malformations (AVMs) present no pathologic tissue, and radiation dose is confined in a clear targeted volume. The authors retrospectively evaluated the role of the biologically effective dose (BED) after Gamma Knife radiosurgery (GKRS) for brain AVMs. A total of 149 consecutive cases of unruptured AVMs treated by upfront GKRS in Lille University Hospital, France, were included. The mean length of follow-up was 52.9 months (median 48, range 12-154 months). The primary outcome was obliteration, and the secondary outcome was complication appearance. The marginal dose was 24 Gy in a vast majority of cases (n = 115, 77.2%; range 18-25 Gy). The mean BED was 220.1 Gy2.47 (median 229.9, range 106.7-246.8 Gy2.47). The mean beam-on time was 32.3 minutes (median 30.8, range 9-138.7 minutes). In the present series, the mean radiation dose rate was 2.259 Gy/min (median 2.176, range 1.313-3.665 Gy/min). The Virginia score was 0 in 29 (19.5%), 1 in 61 (40.9%), 2 in 41 (27.5%), 3 in 18 (12.1%), and 4 in 0 (0%) patients, respectively. The mean Pollock-Flickinger score was 1.11 (median 1.52, range 0.4-2.9). Univariate (for obliteration and complication appearance) and multivariate (for obliteration only) analyses were performed. A total of 104 AVMs (69.8%) were obliterated at the last follow-up. The strongest predictor for obliteration was BED (p = 0.03). A radiosurgical obliteration score is proposed, derived from a fitted multivariable model: (0.018 × BED) + (1.58 × V12) + (-0.013689 × beam-on time) + (0.021 × age) - 4.38. The area under the receiver operating characteristic curve was 0.7438; after internal validation using bootstrap methods, it was 0.7088. No statistically significant relationship between radiation dose rate and obliteration was found (p = 0.29). Twenty-eight (18.8%) patients developed complications after GKRS; 20 (13.4%) of these patients had transient adverse radiological effects (perilesional edema developed). Predictors for complication appearance were higher prescription isodose volume (p = 0.005) and 12-Gy isodose line volume (V12; p = 0.001), higher Pollock-Flickinger (p = 0.02) and Virginia scores (p = 0.003), and lower beam-on time (p = 0.03). The BED was the strongest predictor of obliteration of unruptured AVMs after upfront GKRS. A radiosurgical score comprising the BED is proposed. The V12 appears as a predictor for both efficacy and toxicity. Beam-on time was illustrated as statistically significant for both obliteration and complication appearance. The radiation dose rate did not influence obliteration in the current analysis. The exact BED threshold remains to be established by further studies.</description><identifier>ISSN: 0022-3085</identifier><identifier>ISSN: 1933-0693</identifier><identifier>EISSN: 1933-0693</identifier><identifier>DOI: 10.3171/2020.4.JNS201250</identifier><identifier>PMID: 32707557</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Adult ; Aged ; Arteriovenous Fistula - diagnosis ; Arteriovenous Fistula - epidemiology ; Arteriovenous Fistula - radiotherapy ; Female ; Follow-Up Studies ; France - epidemiology ; Humans ; Intracranial Arteriovenous Malformations - diagnosis ; Intracranial Arteriovenous Malformations - epidemiology ; Intracranial Arteriovenous Malformations - radiotherapy ; Male ; Middle Aged ; Predictive Value of Tests ; Radiation Dosage ; Radiosurgery - methods ; Retrospective Studies ; Treatment Outcome ; Young Adult</subject><ispartof>Journal of neurosurgery, 2021-06, Vol.134 (6), p.1901-1911</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c341t-d2f8556f082b0a27fabdd0531e4094fe8028f2882cc785301484e0eb4972e21b3</citedby><cites>FETCH-LOGICAL-c341t-d2f8556f082b0a27fabdd0531e4094fe8028f2882cc785301484e0eb4972e21b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32707557$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tuleasca, Constantin</creatorcontrib><creatorcontrib>Peciu-Florianu, Iulia</creatorcontrib><creatorcontrib>Leroy, Henri-Arthur</creatorcontrib><creatorcontrib>Vermandel, Maximilien</creatorcontrib><creatorcontrib>Faouzi, Mohamed</creatorcontrib><creatorcontrib>Reyns, Nicolas</creatorcontrib><title>Biologically effective dose and prediction of obliteration of unruptured arteriovenous malformations treated by upfront Gamma Knife radiosurgery: a series of 149 consecutive cases</title><title>Journal of neurosurgery</title><addtitle>J Neurosurg</addtitle><description>Arteriovenous malformations (AVMs) present no pathologic tissue, and radiation dose is confined in a clear targeted volume. The authors retrospectively evaluated the role of the biologically effective dose (BED) after Gamma Knife radiosurgery (GKRS) for brain AVMs. A total of 149 consecutive cases of unruptured AVMs treated by upfront GKRS in Lille University Hospital, France, were included. The mean length of follow-up was 52.9 months (median 48, range 12-154 months). The primary outcome was obliteration, and the secondary outcome was complication appearance. The marginal dose was 24 Gy in a vast majority of cases (n = 115, 77.2%; range 18-25 Gy). The mean BED was 220.1 Gy2.47 (median 229.9, range 106.7-246.8 Gy2.47). The mean beam-on time was 32.3 minutes (median 30.8, range 9-138.7 minutes). In the present series, the mean radiation dose rate was 2.259 Gy/min (median 2.176, range 1.313-3.665 Gy/min). The Virginia score was 0 in 29 (19.5%), 1 in 61 (40.9%), 2 in 41 (27.5%), 3 in 18 (12.1%), and 4 in 0 (0%) patients, respectively. The mean Pollock-Flickinger score was 1.11 (median 1.52, range 0.4-2.9). Univariate (for obliteration and complication appearance) and multivariate (for obliteration only) analyses were performed. A total of 104 AVMs (69.8%) were obliterated at the last follow-up. The strongest predictor for obliteration was BED (p = 0.03). A radiosurgical obliteration score is proposed, derived from a fitted multivariable model: (0.018 × BED) + (1.58 × V12) + (-0.013689 × beam-on time) + (0.021 × age) - 4.38. The area under the receiver operating characteristic curve was 0.7438; after internal validation using bootstrap methods, it was 0.7088. No statistically significant relationship between radiation dose rate and obliteration was found (p = 0.29). Twenty-eight (18.8%) patients developed complications after GKRS; 20 (13.4%) of these patients had transient adverse radiological effects (perilesional edema developed). Predictors for complication appearance were higher prescription isodose volume (p = 0.005) and 12-Gy isodose line volume (V12; p = 0.001), higher Pollock-Flickinger (p = 0.02) and Virginia scores (p = 0.003), and lower beam-on time (p = 0.03). The BED was the strongest predictor of obliteration of unruptured AVMs after upfront GKRS. A radiosurgical score comprising the BED is proposed. The V12 appears as a predictor for both efficacy and toxicity. Beam-on time was illustrated as statistically significant for both obliteration and complication appearance. The radiation dose rate did not influence obliteration in the current analysis. The exact BED threshold remains to be established by further studies.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Arteriovenous Fistula - diagnosis</subject><subject>Arteriovenous Fistula - epidemiology</subject><subject>Arteriovenous Fistula - radiotherapy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>France - epidemiology</subject><subject>Humans</subject><subject>Intracranial Arteriovenous Malformations - diagnosis</subject><subject>Intracranial Arteriovenous Malformations - epidemiology</subject><subject>Intracranial Arteriovenous Malformations - radiotherapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Radiation Dosage</subject><subject>Radiosurgery - methods</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0022-3085</issn><issn>1933-0693</issn><issn>1933-0693</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kc1u1TAQRi0EopfCnhXykk1ux2MnTthBVUqhggWwjhxnXBklcbDjSve5eEF8-7eybJ_vaEYfY28F7KXQ4gwBYa_2X7__RBBYwzO2E52UFTSdfM52AIiVhLY-Ya9S-gMgGtXgS3YiUYOua71j_z75MIUbb800HTg5R3bzt8THkIibZeRrpNGXt7Dw4HgYJr9RNI_3vMS8brkw3MTy4cMtLSEnPpvJhTjfgYlvkcxWmOHA8-piWDZ-aebZ8G-Ld8SjGX1IOd5QPHzghqcionT0C9VxWwxk891Y1iRKr9kLZ6ZEbx7OU_b788Wv8y_V9Y_Lq_OP15WVSmzViK6t68ZBiwMY1M4M4wi1FKSgU45awNZh26K1uq0lCNUqAhpUp5FQDPKUvb_3rjH8zZS2fvbJ0jSZhcqOPSrU2DWy0QWFe9TGkFIk16_RzyYeegH9sar-WFWv-qeqSuTdgz0PM41Pgcdu5H87T5MO</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Tuleasca, Constantin</creator><creator>Peciu-Florianu, Iulia</creator><creator>Leroy, Henri-Arthur</creator><creator>Vermandel, Maximilien</creator><creator>Faouzi, Mohamed</creator><creator>Reyns, Nicolas</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210601</creationdate><title>Biologically effective dose and prediction of obliteration of unruptured arteriovenous malformations treated by upfront Gamma Knife radiosurgery: a series of 149 consecutive cases</title><author>Tuleasca, Constantin ; Peciu-Florianu, Iulia ; Leroy, Henri-Arthur ; Vermandel, Maximilien ; Faouzi, Mohamed ; Reyns, Nicolas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-d2f8556f082b0a27fabdd0531e4094fe8028f2882cc785301484e0eb4972e21b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Arteriovenous Fistula - diagnosis</topic><topic>Arteriovenous Fistula - epidemiology</topic><topic>Arteriovenous Fistula - radiotherapy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>France - epidemiology</topic><topic>Humans</topic><topic>Intracranial Arteriovenous Malformations - diagnosis</topic><topic>Intracranial Arteriovenous Malformations - epidemiology</topic><topic>Intracranial Arteriovenous Malformations - radiotherapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Radiation Dosage</topic><topic>Radiosurgery - methods</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tuleasca, Constantin</creatorcontrib><creatorcontrib>Peciu-Florianu, Iulia</creatorcontrib><creatorcontrib>Leroy, Henri-Arthur</creatorcontrib><creatorcontrib>Vermandel, Maximilien</creatorcontrib><creatorcontrib>Faouzi, Mohamed</creatorcontrib><creatorcontrib>Reyns, Nicolas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tuleasca, Constantin</au><au>Peciu-Florianu, Iulia</au><au>Leroy, Henri-Arthur</au><au>Vermandel, Maximilien</au><au>Faouzi, Mohamed</au><au>Reyns, Nicolas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biologically effective dose and prediction of obliteration of unruptured arteriovenous malformations treated by upfront Gamma Knife radiosurgery: a series of 149 consecutive cases</atitle><jtitle>Journal of neurosurgery</jtitle><addtitle>J Neurosurg</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>134</volume><issue>6</issue><spage>1901</spage><epage>1911</epage><pages>1901-1911</pages><issn>0022-3085</issn><issn>1933-0693</issn><eissn>1933-0693</eissn><abstract>Arteriovenous malformations (AVMs) present no pathologic tissue, and radiation dose is confined in a clear targeted volume. The authors retrospectively evaluated the role of the biologically effective dose (BED) after Gamma Knife radiosurgery (GKRS) for brain AVMs. A total of 149 consecutive cases of unruptured AVMs treated by upfront GKRS in Lille University Hospital, France, were included. The mean length of follow-up was 52.9 months (median 48, range 12-154 months). The primary outcome was obliteration, and the secondary outcome was complication appearance. The marginal dose was 24 Gy in a vast majority of cases (n = 115, 77.2%; range 18-25 Gy). The mean BED was 220.1 Gy2.47 (median 229.9, range 106.7-246.8 Gy2.47). The mean beam-on time was 32.3 minutes (median 30.8, range 9-138.7 minutes). In the present series, the mean radiation dose rate was 2.259 Gy/min (median 2.176, range 1.313-3.665 Gy/min). The Virginia score was 0 in 29 (19.5%), 1 in 61 (40.9%), 2 in 41 (27.5%), 3 in 18 (12.1%), and 4 in 0 (0%) patients, respectively. The mean Pollock-Flickinger score was 1.11 (median 1.52, range 0.4-2.9). Univariate (for obliteration and complication appearance) and multivariate (for obliteration only) analyses were performed. A total of 104 AVMs (69.8%) were obliterated at the last follow-up. The strongest predictor for obliteration was BED (p = 0.03). A radiosurgical obliteration score is proposed, derived from a fitted multivariable model: (0.018 × BED) + (1.58 × V12) + (-0.013689 × beam-on time) + (0.021 × age) - 4.38. The area under the receiver operating characteristic curve was 0.7438; after internal validation using bootstrap methods, it was 0.7088. No statistically significant relationship between radiation dose rate and obliteration was found (p = 0.29). Twenty-eight (18.8%) patients developed complications after GKRS; 20 (13.4%) of these patients had transient adverse radiological effects (perilesional edema developed). Predictors for complication appearance were higher prescription isodose volume (p = 0.005) and 12-Gy isodose line volume (V12; p = 0.001), higher Pollock-Flickinger (p = 0.02) and Virginia scores (p = 0.003), and lower beam-on time (p = 0.03). The BED was the strongest predictor of obliteration of unruptured AVMs after upfront GKRS. A radiosurgical score comprising the BED is proposed. The V12 appears as a predictor for both efficacy and toxicity. Beam-on time was illustrated as statistically significant for both obliteration and complication appearance. The radiation dose rate did not influence obliteration in the current analysis. The exact BED threshold remains to be established by further studies.</abstract><cop>United States</cop><pmid>32707557</pmid><doi>10.3171/2020.4.JNS201250</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3085
ispartof Journal of neurosurgery, 2021-06, Vol.134 (6), p.1901-1911
issn 0022-3085
1933-0693
1933-0693
language eng
recordid cdi_proquest_miscellaneous_2427296367
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adolescent
Adult
Aged
Arteriovenous Fistula - diagnosis
Arteriovenous Fistula - epidemiology
Arteriovenous Fistula - radiotherapy
Female
Follow-Up Studies
France - epidemiology
Humans
Intracranial Arteriovenous Malformations - diagnosis
Intracranial Arteriovenous Malformations - epidemiology
Intracranial Arteriovenous Malformations - radiotherapy
Male
Middle Aged
Predictive Value of Tests
Radiation Dosage
Radiosurgery - methods
Retrospective Studies
Treatment Outcome
Young Adult
title Biologically effective dose and prediction of obliteration of unruptured arteriovenous malformations treated by upfront Gamma Knife radiosurgery: a series of 149 consecutive cases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A31%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biologically%20effective%20dose%20and%20prediction%20of%20obliteration%20of%20unruptured%20arteriovenous%20malformations%20treated%20by%20upfront%20Gamma%20Knife%20radiosurgery:%20a%20series%20of%20149%20consecutive%20cases&rft.jtitle=Journal%20of%20neurosurgery&rft.au=Tuleasca,%20Constantin&rft.date=2021-06-01&rft.volume=134&rft.issue=6&rft.spage=1901&rft.epage=1911&rft.pages=1901-1911&rft.issn=0022-3085&rft.eissn=1933-0693&rft_id=info:doi/10.3171/2020.4.JNS201250&rft_dat=%3Cproquest_cross%3E2427296367%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2427296367&rft_id=info:pmid/32707557&rfr_iscdi=true